다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie, v.69 no.4, 2017년, pp.179 - 186
Kangawa, Y. , Yoshida, T. , Abe, H. , Seto, Y. , Miyashita, T. , Nakamura, M. , Kihara, T. , Hayashi, S.m. , Shibutani, M.
AI-Helper
Developing effective treatments and preventing inflammatory bowel disease (IBD) are urgent challenges in improving patients' health. It has been suggested that platelet activation and reactive oxidative species generation are involved in the pathogenesis of IBD. We examined the inhibitory effects of...
Cytokine Growth Factor Rev. Aguilera 25 715 2014 10.1016/j.cytogfr.2014.04.003 The complex role of inflammasomes in the pathogenesis of Inflammatory Bowel Diseases - lessons learned from experimental models
Endocr. Rev. Azevedo 35 195 2014 10.1210/er.2013-1053 Clinical and molecular genetics of the phosphodiesterases (PDEs)
Saudi J. Gastroenterol. Balmus 22 3 2016 10.4103/1319-3767.173753 The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: clinical aspects and animal models
Clin. Nutr. Camuesco 25 466 2006 10.1016/j.clnu.2005.12.009 Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis
Gastroenterology Collins 106 840 1994 10.1016/0016-5085(94)90741-2 Platelets circulate in an activated state in inflammatory bowel disease
FDA, US 2007 Agency Response Letter GRAS Notice No. GRN00220 [Alpha-glycosyl Isoquercitrin]
J. Inflamm. Res. Fakhoury 7 113 2014 10.2147/JIR.S65979 Inflammatory bowel disease: clinical aspects and treatments
ISRN Inflamm. Galvez 2014 928461 2014 10.1155/2014/928461 Role of Th17Cells in the pathogenesis of human IBD
Pharmacol. Rep. Goraca 63 849 2011 10.1016/S1734-1140(11)70600-4 Lipoic acid - biological activity and therapeutic potential
Exp. Neurol. Hase 233 523 2012 10.1016/j.expneurol.2011.11.038 Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia
J. Vasc. Surg. Hiatt 47 330 2008 10.1016/j.jvs.2007.10.009 Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: a Study in Long-term Effects)
Scand. J. Gastroenterol. Higashiyama 47 993 2012 10.3109/00365521.2012.690043 Indomethacin-induced small intestinal injury is ameliorated by cilostazol, a specific PDE-3 inhibitor
Nucleic Acids Res. Huang da 37 1 2009 10.1093/nar/gkn923 Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Nat. Protoc. Huang da 4 44 2009 10.1038/nprot.2008.211 Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
J. Thromb. Haemost. Hubbard 1 1079 2003 10.1046/j.1538-7836.2003.00212.x Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway
Nutr. Res. Hur 32 801 2012 10.1016/j.nutres.2012.09.013 Review of natural products actions on cytokines in inflammatory bowel disease
Biochem. Pharmacol. Ko 68 2087 2004 10.1016/j.bcp.2004.06.030 Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships
Toxicology Kuwata 283 8 2011 10.1016/j.tox.2011.01.020 Concomitant apoptosis and regeneration of liver cells as a mechanism of liver-tumor promotion by beta-naphthoflavone involving TNFalpha-signaling due to oxidative cellular stress in rats
Biochem. Pharmacol. Kwon 69 395 2005 10.1016/j.bcp.2004.10.015 Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression
J. Agric. Food Chem. Lai 58 8596 2010 10.1021/jf101518p Antiplatelet activity of alpha-lipoic acid
Pharmacol. Res. Mascaraque 90 48 2014 10.1016/j.phrs.2014.09.005 Rutin has intestinal antiinflammatory effects in the CD4+ CD62L+ T cell transfer model of colitis
Am. J. Physiol. Gastrointest. Liver Physiol. Matsunaga 297 G1077 2009 10.1152/ajpgi.00240.2009 Cilostazol, a specific PDE-3 inhibitor, ameliorates chronic ileitis via suppression of interaction of platelets with monocytes
World J. Gastroenterol. Meier 17 3204 2011 Current treatment of ulcerative colitis
Food Chem. Toxicol. Nyska 97 354 2016 10.1016/j.fct.2016.09.030 Ninety-day toxicity and single-dose toxicokinetics study of alpha-glycosyl isoquercitrin in Sprague-Dawley rats
J. Membr. Biol. O’Grady 185 137 2002 10.1007/s00232-001-0120-3 Cyclic AMP-dependent Cl secretion is regulated by multiple phosphodiesterase subtypes in human colonic epithelial cells
J. Biomed. Biotechnol. Perse 718617 2012 Dextran sodium sulphate colitis mouse model: traps and tricks
Br. J. Pharmacol. Pitchford 152 987 2007 10.1038/sj.bjp.0707364 Novel uses for anti-platelet agents as anti-inflammatory drugs
Am. J. Physiol. Ren. Physiol. Ranganathan 305 F1422 2013 10.1152/ajprenal.00319.2013 CXCR2 knockout mice are protected against DSS-colitis-induced acute kidney injury and inflammation
Braz. J. Med. Biol. Res. Sales-Campos 48 96 2015 10.1590/1414-431X20143774 Classical and recent advances in the treatment of inflammatory bowel diseases
Food Chem. Toxicol. Salim 42 1949 2004 10.1016/j.fct.2004.07.010 Lack of carcinogenicity of enzymatically modified isoquercitrin in F344/DuCrj rats
Life Sci. Sann 92 708 2013 10.1016/j.lfs.2013.01.028 Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice
Diabetes Obes. Metab. Schror 4 Suppl. 2 S14 2002 10.1046/j.1463-1326.2002.0040s2s14.x The pharmacology of cilostazol
Biochim. Biophys. Acta Shay 1790 1149 2009 10.1016/j.bbagen.2009.07.026 Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential
Toxicology Shimada 268 213 2010 10.1016/j.tox.2009.12.019 Antioxidant enzymatically modified isoquercitrin suppresses the development of liver preneoplastic lesions in rats induced by beta-naphthoflavone
Am. J. Physiol. Gastrointest. Liver Physiol. Singh 305 G225 2013 10.1152/ajpgi.00091.2013 Deletion of cationic amino acid transporter 2 exacerbates dextran sulfate sodium colitis and leads to an IL-17-predominant T cell response
Oxid. Med. Cell. Longevity Skibska 313021 2015 The protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stress
Smith, R.L., Cohen, S.M., Doull, J., Feron, V.J., Goodman, J.I., Marnett, L.J., Portoghese, P.S., Waddell, W.J., Wagneb, M.R., Adams, T.B., 2005. GRAS flavouring substances. Food Technology 22; 24-62.
Int. J. Clin. Exp. Med. Sun 8 358 2015 Alpha-lipoic acid attenuates trinitrobenzene sulfonic acid-induced ulcerative colitis in mice
J. Immunol. Takada 184 2671 2010 10.4049/jimmunol.0804012 Monocyte chemoattractant protein-1 contributes to gut homeostasis and intestinal inflammation by composition of IL-10-producing regulatory macrophage subset
Int. J. Cardiovasc. Imaging Takeda 28 1181 2012 10.1007/s10554-011-9910-6 Beneficial effect of anti-platelet therapies on atherosclerotic lesion formation assessed by phase-contrast X-ray CT imaging
Toxicol. Lett. Taniai 224 64 2014 10.1016/j.toxlet.2013.10.001 Ochratoxin A induces karyomegaly and cell cycle aberrations in renal tubular cells without relation to induction of oxidative stress responses in rats
Am. J. Physiol. Gastrointest. Liver Physiol. Temmesfeld-Wollbruck 297 G43 2009 10.1152/ajpgi.90532.2008 Adrenomedullin reduces intestinal epithelial permeability in vivo and in vitro
Food Chem. Toxicol. Trivedi 59 339 2013 10.1016/j.fct.2013.06.019 Role of alpha-lipoic acid in dextran sulfate sodium-induced ulcerative colitis in mice: studies on inflammation, oxidative stress, DNA damage and fibrosis
Food Chem. Toxicol. Valentova 68 267 2014 10.1016/j.fct.2014.03.018 Isoquercitrin pharmacology, toxicology, and metabolism
Food Technol. Waddell 23 22 2007 GRAS flavouring substances
Exp. Biol. Med. (Maywood) Zhu 237 474 2012 10.1258/ebm.2011.011358 Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.